ExploreWatchlistsPricing
  1. JP-listed companies
  2. J Frontier Co.,Ltd.
  3. Financials
  4. Capital expenditures

J Frontier Co.,Ltd. (2934)

Market cap
¥8.2B
P/E ratio
79.4x
J-Frontier develops and sells health supplements and pharmaceuticals while operating SOKUYAKU, a medical platform for online consultations and prescription delivery.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
May 31, 2025-39-57.62%
May 31, 2024-91-9.10%
May 31, 2023-100+1204.63%
May 31, 2022-8+11.00%
May 31, 2021-7+34.83%
May 31, 2020-5-84.94%
May 31, 2019-34

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat